Alto Neuroscience Analyst Price Targets - Benzinga

Alto Neuroscience Inc

ANRONYSE

Trade with Public

Trade with Public

$21.94

-0.68-3.01%

最終更新: Oct 16, 7:17 AM

$22.17

-0.45-1.99%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

© 2026 Benzinga | All Rights Reserved

Alto Neuroscience Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alto Neuroscience (ANRO).

Price Target Range — 10 Quarters

Analyst Consensus — 9 Analysts

8Buy

1Hold

Consensus RatingBuy# Analysts9Avg. Consensus PT$30Upside to Avg. PT+35.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 17, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Raise	Buy	$50→$55
Aug 13, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$24→$26
Aug 13, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$28→$37
May 18, 2026	Baird	Brian Skorney	PT Cut	Outperform	$38→$36
May 14, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$21→$24
May 11, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Apr 22, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$30
Apr 2, 2026	Baird	Brian Skorney	PT Cut	Outperform	$41→$38
Apr 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio	Maintained	Buy	$50
Apr 2, 2026	Jones Trading	Justin Walsh	PT Cut	Buy	$49→$44
Apr 2, 2026	Wedbush	Laura Chico	PT Cut	Neutral	$22→$21
Apr 2, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$30
Mar 18, 2026	Baird	Brian Skorney	PT Raise	Outperform	$22→$41
Mar 17, 2026	Chardan Capital	Keay Nakae	Maintained	Buy	$30
Mar 17, 2026	Wedbush	Laura Chico	PT Raise	Neutral	$13→$22
Feb 17, 2026	BTIG	Thomas Shrader	PT Raise	Buy	$27→$28
Jan 5, 2026	Chardan Capital	Keay Nakae	PT Raise	Buy	$15→$30
Nov 17, 2025	BTIG	Thomas Shrader	Initiate	Buy	$27
Nov 13, 2025	Baird	Brian Skorney	PT Raise	Outperform	$16→$22
Nov 12, 2025	Jefferies	Andrew Tsai	PT Raise	Buy	$15→$25

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Alto Neuroscience, Raises Price Target to $55

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $50 to $55.

Benzinga Newsdesk

PRO
Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $26

Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $24 to $26.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on Alto Neuroscience, Raises Price Target to $37

BTIG analyst Thomas Shrader maintains Alto Neuroscience (NYSE:ANRO) with a Buy and raises the price target from $28 to $37.

Benzinga Newsdesk

PRO
Baird Maintains Outperform on Alto Neuroscience, Lowers Price Target to $36

Baird analyst Brian Skorney maintains Alto Neuroscience (NYSE:ANRO) with a Outperform and lowers the price target from $38 to $36.

Benzinga Newsdesk

PRO
Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $24

Wedbush analyst Laura Chico maintains Alto Neuroscience (NYSE:ANRO) with a Neutral and raises the price target from $21 to $24.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Alto Neuroscience, Maintains $50 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $50 price target.

Benzinga Newsdesk